Literature DB >> 28130066

Timing Affects Measurement of Portal Pressure Gradient After Placement of Transjugular Intrahepatic Portosystemic Shunts in Patients With Portal Hypertension.

Gilberto Silva-Junior1, Fanny Turon1, Anna Baiges1, Eira Cerda1, Ángeles García-Criado2, Annabel Blasi3, Ferran Torres4, Virginia Hernandez-Gea5, Jaume Bosch6, Juan Carlos Garcia-Pagan7.   

Abstract

BACKGROUND & AIMS: A reduction in portal pressure gradient (PPG) to <12 mm Hg after placement of a transjugular intrahepatic portosystemic shunt (TIPS) correlates with the absence of further bleeding or ascites at follow-up examinations of patients with cirrhosis. The PPG is usually measured immediately after placement of the TIPS, when different circumstances can affect PPG values, which could affect determination of risk for decompensation. We investigated variations in PPG measurements collected at different time points after TIPS, aiming to identify a time point after which PPG values were best maintained.
METHODS: We performed a retrospective study of 155 consecutive patients with severe complications of portal hypertension who received placement of TIPS from January 2008 through October 2015; patients were followed until March 2016. We compared PPG values measured at different time points and under different conditions: immediately after placement of TIPS (immediate PPG); at least 24 hours after placement to TIPS into hemodynamically stable patients, without sedation (early PPG); and again 1 month after TIPS placement (late PPG).
RESULTS: The immediate PPG differed significantly from the early PPG, regardless of whether the TIPS was placed using general anesthesia (8.5 ± 3.5 mm Hg vs 10 ± 3.5 mm Hg; P = .015) or deep sedation (12 ± 4 mm Hg vs 10.5 ± 4 mm Hg; P <.001). In considering the 12 mm Hg threshold, concordance between immediate PPG and early PPG values was poor. However, there was no significant difference between mean early PPG and late PPG values (8.5 ± 2.5 mm Hg vs 8 ± 3 mm Hg), or between proportions of patients with early PPG vs late PPG values <12 mm Hg threshold. Maintenance of a PPG value <12 mm Hg during the follow-up period was associated with a lower risk of recurrent or de novo variceal bleeding or ascites (hazard ratio, 0.11; 95% confidence interval, 0.04 0.27; P < .001).
CONCLUSIONS: In a retrospective study of patients with PPG values measured at different time points after TIPS placement, we found measurements of PPG in awake, hemodynamically stable patients at least 24 hours after TIPS to be the best maintained values. Our findings support the concept that PPG value <12 mm Hg after TIPS placement is associated with reduced risk of bleeding and ascites.
Copyright © 2017 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Liver Cirrhosis; Portal Hypertension; Portal Pressure Measurement

Mesh:

Year:  2017        PMID: 28130066     DOI: 10.1053/j.gastro.2017.01.011

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  12 in total

1.  Predicting death or recurrence of portal hypertension symptoms after TIPS procedures.

Authors:  Shawn H Sun; Thomas Eche; Chloé Dorczynski; Philippe Otal; Paul Revel-Mouroz; Charline Zadro; Ephraim Partouche; Nadim Fares; Charlotte Maulat; Christophe Bureau; Lawrence H Schwartz; Hervé Rousseau; Laurent Dercle; Fatima-Zohra Mokrane
Journal:  Eur Radiol       Date:  2022-01-11       Impact factor: 5.315

Review 2.  Imaging-guided interventions modulating portal venous flow: Evidence and controversies.

Authors:  Roberto Cannella; Lambros Tselikas; Fréderic Douane; François Cauchy; Pierre-Emmanuel Rautou; Rafael Duran; Maxime Ronot
Journal:  JHEP Rep       Date:  2022-04-04

3.  Retrospective Study of Transjugular Intrahepatic Portosystemic Shunt Placement for Cirrhotic Portal Hypertension.

Authors:  Sara Santos; Eduardo Dantas; Filipe Veloso Gomes; José Hugo Luz; Nuno Vasco Costa; Tiago Bilhim; Filipe Calinas; Américo Martins; Élia Coimbra
Journal:  GE Port J Gastroenterol       Date:  2020-06-09

4.  Transjugular intrahepatic portosystemic shunts (TIPS) for the prevention of variceal re-bleeding - A two decades experience.

Authors:  Theresa Bucsics; Maria Schoder; Magdalena Diermayr; Maria Feldner-Busztin; Nicolas Goeschl; David Bauer; Philipp Schwabl; Mattias Mandorfer; Bernhard Angermayr; Manfred Cejna; Arnulf Ferlitsch; Wolfgang Sieghart; Michael Trauner; Markus Peck-Radosavljevic; Josef Karner; Franz Karnel; Thomas Reiberger
Journal:  PLoS One       Date:  2018-01-09       Impact factor: 3.240

5.  Ascites control by TIPS is more successful in patients with a lower paracentesis frequency and is associated with improved survival.

Authors:  Felix Piecha; Ulf K Radunski; Ann-Kathrin Ozga; David Steins; Andreas Drolz; Thomas Horvatits; Clemens Spink; Harald Ittrich; Daniel Benten; Ansgar W Lohse; Christoph Sinning; Johannes Kluwe
Journal:  JHEP Rep       Date:  2019-05-10

6.  Risk factors for stent graft thrombosis after transjugular intrahepatic portosystemic shunt creation.

Authors:  Younes Jahangiri; Timothy Kerrigan; Lei Li; Dominik Prosser; Anantnoor Brar; Johnathan Righetti; Ryan C Schenning; John A Kaufman; Khashayar Farsad
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

7.  Outcomes After TIPS for Ascites and Variceal Bleeding in a Contemporary Era-An ALTA Group Study.

Authors:  Justin Richard Boike; Nikhilesh Ray Mazumder; Kanti Pallav Kolli; Jin Ge; Margarita German; Nathaniel Jest; Giuseppe Morelli; Erin Spengler; Adnan Said; Jennifer C Lai; Archita P Desai; Thomas Couri; Sonali Paul; Catherine Frenette; Elizabeth C Verna; Usman Rahim; Aparna Goel; Dyanna Gregory; Bartley Thornburg; Lisa B VanWagner
Journal:  Am J Gastroenterol       Date:  2021-10-01       Impact factor: 12.045

Review 8.  Preoperative elective transjugular intrahepatic portosystemic shunt for cirrhotic patients undergoing abdominal surgery.

Authors:  Deepanshu Jain; Ejaz Mahmood; Maria V-Bandres; Eyob Feyssa
Journal:  Ann Gastroenterol       Date:  2018-03-15

Review 9.  North American Practice-Based Recommendations for Transjugular Intrahepatic Portosystemic Shunts in Portal Hypertension.

Authors:  Justin R Boike; Bartley G Thornburg; Sumeet K Asrani; Michael B Fallon; Brett E Fortune; Manhal J Izzy; Elizabeth C Verna; Juan G Abraldes; Andrew S Allegretti; Jasmohan S Bajaj; Scott W Biggins; Michael D Darcy; Maryjane A Farr; Khashayar Farsad; Guadalupe Garcia-Tsao; Shelley A Hall; Caroline C Jadlowiec; Michael J Krowka; Jeanne Laberge; Edward W Lee; David C Mulligan; Mitra K Nadim; Patrick G Northup; Riad Salem; Joseph J Shatzel; Cathryn J Shaw; Douglas A Simonetto; Jonathan Susman; K Pallav Kolli; Lisa B VanWagner
Journal:  Clin Gastroenterol Hepatol       Date:  2021-07-15       Impact factor: 13.576

10.  Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension.

Authors:  Dhiraj Tripathi; Adrian J Stanley; Peter C Hayes; Simon Travis; Matthew J Armstrong; Emmanuel A Tsochatzis; Ian A Rowe; Nicholas Roslund; Hamish Ireland; Mandy Lomax; Joanne A Leithead; Homoyon Mehrzad; Richard J Aspinall; Joanne McDonagh; David Patch
Journal:  Gut       Date:  2020-02-29       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.